Drugs / Ara-C: Cytarabine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01449344 | May 2009 → Dec 2018 | mantle cell lymphoma | Prof. Dr. M. Dreyling (co-chairman) | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ara-C: Cytarabine | “Ara-C: Cytarabine” NCT01449344 ↗ |
| Known as | Ara-C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01449344 ↗ |